Home › News and Press › Page 3

News and Press releases

View all News Press releases

Oxcia AB presents positive effects of OXC-201 in lung tissue from patient with Idiopatic Pulmonary Fibrosis

October 23, 2023 · News and Press

Austin Smith, CMO, attends ESMO congress

October 19, 2023 · News and Press

Animation of OXC-101’s Mechanism of Action

September 29, 2023 · News and Press

Notice of Extraordinary General Meeting

· News and Press

Sandra Ekstedt presents OXC-201 at the ERS 10th of September

September 4, 2023 · News and Press

Christina Kalderén presents at the IPF Summit September 19-21st

August 31, 2023 · News and Press

Oxcia AB (publ) publishes interim report for the second quarter 2023

August 25, 2023 · News and Press

OXC-101 as a novel therapy for AML will be presented at 18[th] Annual Congress of International Drug Discovert Science & Technology, Amsterdam 12-14 July, 2023

August 23, 2023 · News and Press

OXC-101 as a novel therapy for AML will be presented at 18[th] Annual Congress of International Drug Discovery Science & Technology, Amsterdam 12-14 July, 2023

June 30, 2023 · News and Press

Oxcia AB (publ) publishes annual report

May 16, 2023 · News and Press

Oxcia AB (publ) publishes interim report fort the first quarter 2023

April 26, 2023 · News and Press

Oxcia has been awarded a grant of 3 million SEK for a study in refractory AML patients

April 3, 2023 · News and Press

Search